Limbunan, Alvina .

HRN: 17-64-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/17/2024
07/23/2024
IV
500 Mg
Q8
Amoebic Dysentery
Waiting Final Action 
07/17/2024
CEFTRIAXONE 1G (VIAL)
07/17/2024
07/23/2024
IV
2 G
Q24
Urinary Tract Infection
Waiting Final Action 
07/20/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
07/20/2024
07/27/2024
TOPICAL
BID
Bid
T/C Conjunctivitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: